Park Medi World Limited
Bookbuilding IPO · NSE, BSE
- Price band
- ₹154 - ₹162
- Lot size
- 92 shares
- Issue amount
- ₹920 cr
- Total subscription
- 8.52×
- Opens
- 10 Dec 2025
- Closes
- 12 Dec 2025
- Allotment
- 15 Dec 2025
- Listing
- 17 Dec 2025
Offer at a glance
Issue overview
- Issue size
- 5,67,90,123 shares
- Face value
- ₹2 Per Share
- Minimum investment
- ₹14,168
- Fresh issue
- ₹770 cr
- Offer for sale
- ₹150 cr
- Registrar
- Kfin Technologies Limited
- Listing exchange
- NSE, BSE
- Maximum investment
- ₹14,904
- Issue type
- Bookbuilding IPO
- Shares before issue
- 38,43,99,990
- Shares after issue
- 43,19,30,854
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail | 1 | 92 | ₹14,904 |
| sHNI | 14 | 1,288 | ₹2,08,656 |
| bHNI | 68 | 6,256 | ₹10,13,472 |
Share reservation
Subscription & GMP
Subscription by category
Reported 12 Dec 2025
GMP history
Day-wise demand
Application-wise demand
| Category | Reserved applications | Applied applications |
|---|---|---|
| RETAIL | 2,16,049 | 6,10,981 |
| HNIs(10L +) | 4,409 | 15,638 |
| HNIs (2-10L) | 2,205 | 23,611 |
Subscription demand
Amounts in ₹ crore. HNI subcategories are included in the NII total.
| Category | Offered | Demand |
|---|---|---|
| QIBs | 184 | 2,221.18 |
| FIIs | 0 | 958.77 |
| FIs | 0 | 239.34 |
| Mutual Funds | 0 | 355.55 |
| Others | 0 | 667.52 |
| RETAIL | 322 | 1,069.24 |
| HNIs 2+ | 46 | 511.32 |
| HNIs 10+ | 92 | 1,687.32 |
Financial performance
Company financials
In Crores · Reported periods may include interim results.
Key performance indicators
| Metric | Sep-25 | Mar-25 | Mar-24 |
|---|---|---|---|
| EPS | 0 | 0 | 0 |
| ROE | 11.64 | 20.68 | 18.25 |
| ROCE | 9.55 | 17.47 | 16.07 |
| RONW | 11.45 | 20.08 | 18.81 |
| PRE IPO(PE) | 0 | 29.21 | 0 |
| POST IPO(PE) | 25.14 | 0 | 0 |
Values and labels as reported in the issue data.
Peer comparison
| Company | P/E(X) | CMP* (₹) | Face value (₹) | NAV/Share (₹) | RONW(%) | EPS (Basic) (₹) |
|---|---|---|---|---|---|---|
| Park Medi World Ltd | 0 | 0 | 2.00 | 26.58 | 20.08 | 20.08 |
| Apollo Hospitals Enterprise Limited | 73.43 | 0 | 5.00 | 570.37 | 17.63 | 100.56 |
| Fortis Healthcare Limited | 90.42 | 0 | 10.00 | 118.06 | 8.69 | 10.26 |
| Narayana Hrudalaya Limited | 50.1 | 0 | 10.00 | 177.37 | 21.8 | 38.9 |
| Max Healthcare Institute Limited | 101.54 | 0 | 10.00 | 96.5 | 11.47 | 11.07 |
| Krishna Institute of Medical Sciences Limited | 69.53 | 0 | 2.00 | 53.43 | 17.89 | 9.61 |
| Global Health Limited | 66.41 | 0 | 2.00 | 125.64 | 14.27 | 17.92 |
| Jupiter Lifeline Hospitals Ltd | 48.59 | 0 | 10.00 | 206.85 | 14.27 | 29.47 |
| Yatharth Hospital & Trauma Care Services Limited | 52.85 | 0 | 10.00 | 166.62 | 8.15 | 14.72 |
Company information
Company profile
Park Medi World Limited, incorporated in 2011, is a leading private hospital chain in North India operating 13 NABH-accredited multi-super speciality hospitals with a total capacity of 3,000 beds across Haryana, Delhi, Punjab, and Rajasthan, of which seven are also NABL accredited. The network offers 30+ specialities including internal medicine, neurology, urology, gastroenterology, general surgery, orthopaedics, and oncology, supported by 805 ICU beds, 63 operating theatres, two dedicated cancer units, and oxygen generation plants at every hospital. As of September 30, 2024, the group handled 40,368 in-patient admissions in six months (73,284 in FY24) and employed 891 doctors, 1,912 nurses, 671 medical professionals, and 1,761 support staff.
Strengths
- Large Regional Hospital Network and Market Leadership: One of the largest private healthcare providers in North India and the leading hospital network in Haryana by total bed capacity, supporting strong geographic dominance and patient inflow.
- Comprehensive Specialty Portfolio with Accredited Quality: Offers 30+ medical specialties backed by NABH and NABL certifications, ensuring high clinical standards, patient confidence, and diversified revenue streams.
- Successful Expansion via Acquisitions and Integration Capability: Proven ability to acquire, scale, and integrate hospitals efficiently, improving operational performance and strengthening long-term growth prospects.
Risk factors
- High Contingent Liabilities Creating Financial Exposure: The company has substantial contingent liabilities and guarantees relative to its net worth; if these materialize, they could significantly weaken financial stability and balance sheet strength.
- Vulnerability to Credit Rating Downgrades: Any deterioration in the company’s credit rating may lead to higher borrowing costs and restricted access to capital, adversely impacting margins and liquidity.
- Recent Decline in Revenue and Profitability Trends: The company experienced lower revenue and higher expenses in FY24; continuation of this downward trajectory may negatively affect future growth and financial performance.
Promoters
Dr. Ajit Gupta
Dr. Ankit Gupta
Registrar & documents
Lead manager
Nuvama Wealth Management Limited, Clsa India Private Limited, Dam Capital Advisors Limited, Intensive Fiscal Services Private Limited
Registrar & contacts
Kfin Technologies Limited
[email protected]Official registrar portal ↗IPO allotment status guide →Registered office
12, Meera Enclave Near Keshopur, Bus Depot, Outer Ring Road, New Delhi 110018, Delhi New Delhi, New Delhi, 110018
+ 91 124 696 000
[email protected]Company website ↗Understanding PARKHOSPS IPO data
Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.